PUI
CRL icon

Purpose Unlimited Inc’s Charles River Laboratories CRL Stock Holding History

Purpose Unlimited Inc’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$604K Hold
3,501
– – 0.03% 148
2025
Q4 		$698K Buy
+3,501
New +$635K 0.03% 126

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Purpose Unlimited Inc's CRL Position: Q1 2026 in Review

Purpose Unlimited Inc held its Charles River Laboratories (CRL) position steady in Q1 2026 at 3,501 shares worth $604K. The position accounts for 0.03% of the portfolio, ranked #148.

Purpose Unlimited Inc first reported a position in CRL in Q4 2025 and has held it in 2 quarters since. The position peaked at $698K in Q4 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Purpose Unlimited Inc held 3,501 shares of Charles River Laboratories worth $604K as of Q1 2026.
  • Purpose Unlimited Inc left its Charles River Laboratories share count unchanged in Q1 2026.
  • Charles River Laboratories made up 0.03% of Purpose Unlimited Inc's portfolio in Q1 2026, its #148 holding.
  • Purpose Unlimited Inc first reported a position in Charles River Laboratories in Q4 2025 and has held it in 2 quarters since.
  • Purpose Unlimited Inc's Charles River Laboratories position peaked at $698K in Q4 2025.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Purpose Unlimited Inc's 13F filing for Q1 2026, filed 15 May 2026.